Learn More
Abcam Gardiquimod, toll-like receptor 7 (TLR7) agonist, 5MG
Supplier: Abcam AB1414855MG
MW 313.4 Da, Purity >98%. Selective TLR7 agonist. Inhibits HIV-1 reverse transcriptase. Induces pro-inflammatory cytokine production in thymocytes. Antiproliferative effects. Shows immunomodulatory effects in vivo. More active than Imiquimod (ab141410).
The product is subject to the following: Abcam Restricted Use Statement
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.